Balchem reported record quarterly sales, net earnings and adjusted EBITDA for the third quarter of 2026. The specialty ingredients company released the results on October 23, 2026, covering the three months ended September 30.

Key Insights

  • Net sales increased 8.6% year over year to $290.7 million, with growth across all three operating segments.
  • Net earnings rose 16.0% to $46.7 million, while adjusted EBITDA increased 12.4% to $80.3 million.
  • Free cash flow reached $57.9 million, and Balchem repurchased about $28 million of shares during the quarter.

Balchem Sales Increase 8.6%

Third-quarter net sales rose to $290.658 million from $267.558 million a year earlier. Management said each of Balchem’s three operating segments contributed to the increase, broadening the result beyond a single product line.

The company supplies specialty ingredients used in human nutrition, animal nutrition and industrial applications. Its sales growth adds another data point for investors following health-related businesses, alongside Quest Diagnostics’ updated revenue outlook.

Earnings and Cash Flow Improve

Net earnings increased to $46.728 million from $40.289 million, according to Balchem’s SEC earnings exhibit. Diluted GAAP EPS rose to $1.46 from $1.24, while adjusted EPS increased to $1.57 from $1.35.

Adjusted EBITDA reached $80.297 million, up from $71.447 million in the prior-year period. Operating cash flow totaled $69.8 million and free cash flow was $57.9 million, giving the company additional flexibility for investment and shareholder returns.

Share Buybacks Support Capital Returns

Balchem repurchased approximately $28 million of its shares during the third quarter and about $127 million over the trailing 12 months. The buybacks reduced cash available for other uses but returned capital directly to shareholders as profit and cash generation improved.

Investors will now watch whether broad segment growth and cash conversion remain durable in coming quarters. Comparable company updates include Gentex’s revenue and margin outlook and Popular’s earnings and dividend update.

Elsy Kanana is a financial and cryptocurrency journalist at FusionMarketNews, covering digital assets, blockchain technology, financial markets, and emerging fintech trends. Her reporting focuses on market movements, regulatory developments, and on-chain analytics, delivering clear, data-driven insights to readers worldwide.